APG Asset Management N.V. Trims Stock Position in Waters Corporation $WAT

APG Asset Management N.V. decreased its position in shares of Waters Corporation (NYSE:WAT) by 31.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 35,733 shares of the medical instruments supplier’s stock after selling 16,188 shares during the quarter. APG Asset Management N.V. owned approximately 0.06% of Waters worth $10,713,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in WAT. Root Financial Partners LLC purchased a new position in Waters during the 3rd quarter worth $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Waters in the 3rd quarter valued at approximately $26,000. Hantz Financial Services Inc. increased its position in Waters by 115.4% during the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 60 shares during the period. CYBER HORNET ETFs LLC purchased a new position in shares of Waters during the 2nd quarter worth approximately $53,000. Finally, Versant Capital Management Inc lifted its holdings in Waters by 510.3% in the third quarter. Versant Capital Management Inc now owns 177 shares of the medical instruments supplier’s stock valued at $53,000 after acquiring an additional 148 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on WAT shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research report on Wednesday, January 21st. Barclays assumed coverage on Waters in a research note on Tuesday, February 10th. They set an “overweight” rating and a $400.00 price objective on the stock. Evercore began coverage on shares of Waters in a research note on Tuesday, February 10th. They issued a “hold” rating and a $360.00 target price for the company. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Finally, HSBC started coverage on shares of Waters in a research report on Tuesday, January 27th. They issued a “buy” rating and a $460.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Waters presently has a consensus rating of “Moderate Buy” and a consensus target price of $393.84.

Waters Stock Up 1.8%

WAT stock opened at $312.80 on Wednesday. The company has a market capitalization of $30.69 billion, a P/E ratio of 29.04, a PEG ratio of 2.12 and a beta of 1.20. The firm has a 50 day simple moving average of $365.80 and a 200-day simple moving average of $351.27. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15.

Waters (NYSE:WAT) last released its earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, beating the consensus estimate of $4.50 by $0.03. The firm had revenue of $932.36 million during the quarter, compared to analyst estimates of $928.17 million. Waters had a net margin of 20.30% and a return on equity of 34.79%. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.10 earnings per share. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. On average, equities research analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.